RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SANTINI V
Collezione AOU Alessandria

Items : 6

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes. in The Lancet. Haematology / Lancet Haematol. 2024 Nov;11(11):e862-e872. doi: 10.1016/S2352-3026(24)00251-5. Epub 2024 Oct 9.

2024
AOU Alessandria

Komrokji RS; Lanino L; Ball S; Bewersdorf JP; Marchetti M; Maggioni G; Travaglino E; Al Ali NH; Fenaux P; Platzbecker U; Santini V; Diez-Campelo M; Singh A; Jain AG; Aguirre LE; Tinsley-Vance SM; Schwabkey ZI; Chan O; Xie Z; Brunner AM; Kuykendall AT; Bennett JM; Buckstein R; Bejar R; Carraway HE; DeZern AE; Griffiths EA; Halene S; Hasserjian RP; et alii...

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Oct 1;41(28):4486-4496. doi: 10.1200/JCO.22.02699. Epub 2023 Jun 9.

2023
AOU Alessandria
AOU Città della Salute di Torino

Zini G; D'Errigo MG; Bova I; Rizzo L; Cufari P; Delfino IM; Arcadi MT; Candoni A; Liberati AM; Stamatoullas-Bastard A; Rivellini F; Buccisano F; Di Renzo N; Impera S; Palumbo GA; Germing U; Ricco A; Fenaux P; Molteni A; Bocchia M; Fattizzo B; Beltrami G; Castelli A; Russo E; Tripepi G; Iannì G; Guarini A; Ferrero D; Cascavilla N; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.

2023
AOU Alessandria
ASL Città di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU Città della Salute di Torino

Della Porta MG; Santini V; Naldi I; Pasini P; Giordano L; Finelli C; Turrini M; Sancetta R; Selleri C; Tanasi I; Tosi P; Frigeni M; Marchetti M; Norata M; Grimaldi D; Fianchi L; Galimberti S; Ferrara F; Castelli A; Di Bona E; Di Veroli A; Bono R; Calvisi A; Rivoli G; Molteni A; Nicolino B; Occhini U; Leuzzi L; Genua A; et alii...

Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience. in Leukemia / Leukemia. 2022 Jul;36(7):1947-1950. doi: 10.1038/s41375-022-01592-3. Epub 2022 May 21.

2022
AOU Alessandria
AOU Città della Salute di Torino

Facco M; Binotto G; Pizzi M; Candiotto C; Bertorelle R; Finelli C; Gaidano V; Giai V; Poloni A; Niscola P; Crugnola M; Gasparini VR; Vicenzetto C; Barilà G; Mossuto S; Carraro S; Trimarco V; Teramo A; Attardi E; Calabretto G; Vianello F; Trentin L; Semenzato G; Zambello R; Santini V;

Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 May 1;39(13):1426-1436. doi: 10.1200/JCO.20.02619. Epub 2021 Mar 25.

2021
AOU Alessandria

Garcia-Manero G; Santini V; Almeida A; Platzbecker U; Jonasova A; Silverman LR; Falantes J; Reda G; Buccisano F; Fenaux P; Buckstein R; Diez Campelo M; Larsen S; Valcarcel D; Vyas P; Giai V; Olíva EN; Shortt J; Niederwieser D; Mittelman M; Fianchi L; La Torre I; Zhong J; Laille E; Lopes de Menezes D; Skikne B; Beach CL; Giagounidis A;

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes. in The New England journal of medicine / N Engl J Med. 2020 Jan 9;382(2):140-151. doi: 10.1056/NEJMoa1908892.

2020
AOU Alessandria

Fenaux P; Platzbecker U; Mufti GJ; Garcia-Manero G; Buckstein R; Santini V; Díez-Campelo M; Finelli C; Cazzola M; Ilhan O; Sekeres MA; Falantes JF; Arrizabalaga B; Salvi F; Giai V; Vyas P; Bowen D; Selleslag D; DeZern AE; Jurcic JG; Germing U; Götze KS; Quesnel B; Beyne-Rauzy O; Cluzeau T; Voso MT; Mazure D; Vellenga E; Greenberg PL; et alii...